Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001193125-26-149960
Filing Date
2026-04-09
Accepted
2026-04-09 18:42:43
Documents
2
Period of Report
2026-04-01

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1638
2 EX-24 coya-ex24.htm EX-24 11911
  Complete submission text file 0001193125-26-149960.txt   14991
Mailing Address C/O NITROMED INC 125 SPRING STREET LEXINGTON MA 02421
Business Address
Pavao Mark H (Reporting) CIK: 0001297988 (see all company filings)

Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-41583 | Film No.: 26852784

Mailing Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024
Business Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024 650.739.3939
Coya Therapeutics, Inc. (Issuer) CIK: 0001835022 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)